Insmed To Present at March 2025 Investor Conferences

Company Overview - Insmed Incorporated is a global biopharmaceutical company focused on delivering first- and best-in-class therapies for patients with serious diseases [2][3] - The company is advancing a diverse portfolio of approved and investigational medicines, particularly in pulmonary and inflammatory conditions [2] - Insmed's research includes innovative technologies such as gene therapy, AI-driven protein engineering, and synthetic rescue [2] Recent Announcements - Insmed announced management will present at investor conferences, including the 45th Annual TD Cowen Healthcare Conference on March 3, 2025, and the Leerink Partners Global Healthcare Conference on March 11, 2025 [1][4] - The events will be webcast live and archived for 30 days on the company's website [1]